The International Association for the Study of Pain recently released a statement on the strength of current research on cannabis and cannabinoid use in pain management. What did they find?
A new study on conversion of acute to chronic low back pain identifies clinician behavior as well as patient characteristics that increase that risk.
New and highly specific migraine drugs have significantly changed the clinical landscape for patients. We talked with Peter McAllister, MD, about where the research goes next.
A recent survey queried cluster headache patients to compare cluster headache pain intensity to other painful disorders. The results, highlighted in this quick slideshow, may surprise.
Listen to our newest podcast episode where the lead author of a recent meta-analysis shares his findings on the safety and efficacy of antidepressant medications to treat back and osteoarthritis pain.
A recent meta-analysis assessed comparative clinical efficacy of NSAIDs and COX-2 inhibitors. Try these 7 questions on the findings - does your clinical experience match?
Pain associated with COVID-19 has many causes and may persist after the infection has resolved. Find out what you've learned about pain in the pandemic with these 7 questions.
Cannabis researchers Drs Carrie Cuttler and Rebecca Craft discuss their findings, their labs at WSU, their new research, and what makes this kind of research a challenge.
What is the drug of choice in a patient who is taking aspirin for secondary prevention of stroke? Ibuprofen? Celecoxib? Other? Plus 6 more questions on NSAID use in primary care.
Pain is a common complication of COVID-19 infection, during the illness and afterwards. Click through this summary of new data on acute pain and risk for persistent pain from COVID-19.